{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T08:45:24Z","timestamp":1665650724076},"reference-count":95,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.mehy.2003.12.054","type":"journal-article","created":{"date-parts":[[2004,6,2]],"date-time":"2004-06-02T17:49:16Z","timestamp":1086198556000},"page":"1015-1021","source":"Crossref","is-referenced-by-count":13,"title":["Nutritional modulation of parathyroid hormone secretion may influence risk for left ventricular hypertrophy"],"prefix":"10.1016","volume":"64","author":[{"given":"Mark F.","family":"McCarty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2003.12.054_bib1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0002-9343(97)00142-3","article-title":"Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure","volume":"103","author":"Shane","year":"1997","journal-title":"Am J Med"},{"key":"10.1016\/j.mehy.2003.12.054_bib2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0735-1097(02)02624-4","article-title":"Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure?","volume":"41","author":"Zittermann","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.mehy.2003.12.054_bib3","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1046\/j.1365-2796.2003.01130.x","article-title":"Congestive heart failure is associated with the rate of bone loss","volume":"253","author":"Nishio","year":"2003","journal-title":"J Intern Med"},{"key":"10.1016\/j.mehy.2003.12.054_bib4","first-page":"1553","article-title":"Bone density and laboratory parameters of bone metabolism in patients with terminal heart disease","volume":"126","author":"Christ","year":"1996","journal-title":"Schweiz Med Wochenschr"},{"key":"10.1016\/j.mehy.2003.12.054_bib5","first-page":"508","article-title":"Hyperparathyroidism in congestive heart failure","volume":"104","author":"Schmid","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.mehy.2003.12.054_bib6","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1097\/00004872-199611000-00015","article-title":"Left ventricular mass is linked to cardiac noradrenaline in normotensive and hypertensive patients","volume":"14","author":"Kelm","year":"1996","journal-title":"J Hypertens"},{"issue":"Suppl F","key":"10.1016\/j.mehy.2003.12.054_bib7","first-page":"10F","article-title":"Cardioprotective effect of angiotensin II receptor antagonists","volume":"15","author":"White","year":"1999","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.mehy.2003.12.054_bib8","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1161\/01.HYP.33.4.954","article-title":"Chronic ETA receptor blockade attenuates cardiac hypertrophy independently of blood pressure effects in renovascular hypertensive rats","volume":"33","author":"Ehmke","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.mehy.2003.12.054_bib9","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1291\/hypres.23.377","article-title":"Relationship between hypertensive left ventricular hypertrophy and levels of endothelin and nitric oxide","volume":"23","author":"Hua","year":"2000","journal-title":"Hypertens Res"},{"key":"10.1016\/j.mehy.2003.12.054_bib10","doi-asserted-by":"crossref","first-page":"S348","DOI":"10.1097\/00005344-200036051-00101","article-title":"Endothelin-receptor antagonists in uremic cardiomyopathy","volume":"36","author":"Wolf","year":"2000","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.mehy.2003.12.054_bib11","doi-asserted-by":"crossref","first-page":"15374","DOI":"10.1016\/S0021-9258(18)82267-0","article-title":"The \u03b11A-adrenergic receptor subtype mediates biochemical, molecular, and morphologic features of cultured myocardial cell hypertrophy","volume":"268","author":"Knowlton","year":"1993","journal-title":"J Biol Chem"},{"issue":"Suppl 2","key":"10.1016\/j.mehy.2003.12.054_bib12","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1097\/00005344-199117002-00005","article-title":"Sympathetic activity: modulator of myocardial hypertrophy","volume":"17","author":"Long","year":"1991","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.mehy.2003.12.054_bib13","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0092-8674(93)90541-W","article-title":"Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro","volume":"75","author":"Sadoshima","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.mehy.2003.12.054_bib14","doi-asserted-by":"crossref","first-page":"20555","DOI":"10.1016\/S0021-9258(17)30538-0","article-title":"Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes. A paracrine mechanism for myocardial cell hypertrophy","volume":"265","author":"Shubeita","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2003.12.054_bib15","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1161\/01.CIR.99.3.384","article-title":"Increased protein kinase C activity and expression of Ca2+-sensitive isoforms in the failing human heart","volume":"99","author":"Bowling","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2003.12.054_bib16","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1161\/01.CIR.99.3.334","article-title":"\u03b2-Protein kinase C and hypertrophic signaling in human heart failure","volume":"99","author":"Simpson","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2003.12.054_bib17","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1016\/S0021-9258(17)41927-2","article-title":"An enhancer core element mediates stimulation of kinase C in hypertrophy of the rat \u03b2-myosin heavy chain promoter by an \u03b11-adrenergic agonist and activated \u03b2-protein cardiac myocytes","volume":"269","author":"Kariya","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2003.12.054_bib18","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1074\/jbc.270.1.410","volume":"270","author":"Karns","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2003.12.054_bib19","doi-asserted-by":"crossref","first-page":"9320","DOI":"10.1073\/pnas.94.17.9320","article-title":"Targeted overexpression of protein kinase C \u03b22 isoform in myocardium causes cardiomyopathy","volume":"94","author":"Wakasaki","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2003.12.054_bib20","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1161\/01.CIR.97.15.1433","article-title":"Success in failure: modeling cardiac decompensation in transgenic mice","volume":"97","author":"MacLellan","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2003.12.054_bib21","doi-asserted-by":"crossref","first-page":"8121","DOI":"10.1073\/pnas.94.15.8121","article-title":"Transgenic G\u03b1q overexpression induces cardiac contractile failure in mice","volume":"94","author":"D\u2019Angelo","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2003.12.054_bib22","doi-asserted-by":"crossref","first-page":"10140","DOI":"10.1073\/pnas.95.17.10140","article-title":"Enhanced G\u03b1q signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure","volume":"95","author":"Adams","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2003.12.054_bib23","doi-asserted-by":"crossref","first-page":"13893","DOI":"10.1073\/pnas.95.23.13893","article-title":"Transient cardiac expression of constitutively active G\u03b1q leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways","volume":"95","author":"Mende","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2003.12.054_bib24","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1161\/01.RES.87.12.1085","article-title":"G proteins and heart failure: is G\u03b1q a novel target for heart failure?","volume":"87","author":"Feuerstein","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.mehy.2003.12.054_bib25","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1126\/science.280.5363.574","article-title":"Targeting the receptor\u2013Gq interface to inhibit in vivo pressure overload myocardial hypertrophy","volume":"280","author":"Akhter","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.mehy.2003.12.054_bib26","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/nm1101-1236","article-title":"Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of G\u03b1q\/G\u03b111 in cardiomyocytes","volume":"7","author":"Wettschureck","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.mehy.2003.12.054_bib27","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1172\/JCI2709","article-title":"In vivo phosphorylation of cardiac troponin I by protein kinase C \u03b22 decreases cardiomyocyte calcium responsiveness and contractility in transgenic mouse hearts","volume":"102","author":"Takeishi","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mehy.2003.12.054_bib28","first-page":"H1739","article-title":"Trophic effects of catecholamines and parathyroid hormone on adult ventricular cardiomyocytes","volume":"263","author":"Schluter","year":"1992","journal-title":"Am J Physiol"},{"issue":"Pt 2","key":"10.1016\/j.mehy.2003.12.054_bib29","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1042\/bj3100439","article-title":"Parathyroid hormone induces protein kinase C but not adenylate cyclase in adult cardiomyocytes and regulates cyclic AMP levels via protein kinase C-dependent phosphodiesterase activity","volume":"310","author":"Schluter","year":"1995","journal-title":"Biochem J"},{"key":"10.1016\/j.mehy.2003.12.054_bib30","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0008-6363(97)00194-6","article-title":"Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide","volume":"37","author":"Schluter","year":"1998","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.mehy.2003.12.054_bib31","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000183125","article-title":"Uremic cardiomyopathy: potential role of vitamin D and parathyroid hormone","volume":"36","author":"McGonigle","year":"1984","journal-title":"Nephron"},{"key":"10.1016\/j.mehy.2003.12.054_bib32","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/ki.1987.293","article-title":"Secondary hyperparathyroidism and cardiac hypertrophy in hemodialysis patients","volume":"32","author":"London","year":"1987","journal-title":"Kidney Int"},{"key":"10.1016\/j.mehy.2003.12.054_bib33","first-page":"59","article-title":"The cardiocyte as a target for parathyroid hormone in end-stage renal disease","volume":"5","author":"Meggs","year":"1994","journal-title":"J Assoc Acad Minor Phys"},{"key":"10.1016\/j.mehy.2003.12.054_bib34","first-page":"72","article-title":"Relation between parathyroid hormone and cardiac function in long-term hemodialysis patients","volume":"21","author":"Hara","year":"1995","journal-title":"Miner Electrolyte Metab"},{"key":"10.1016\/j.mehy.2003.12.054_bib35","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0272-6386(99)70260-X","article-title":"Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism","volume":"33","author":"Park","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.mehy.2003.12.054_bib36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1081\/JDI-100001291","article-title":"Parathormon, calcium, phosphorus, and left ventricular structure and function in normotensive hemodialysis patients","volume":"23","author":"Strozecki","year":"2001","journal-title":"Ren Fail"},{"key":"10.1016\/j.mehy.2003.12.054_bib37","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/hrt.54.5.539","article-title":"Cardiac hypertrophy, hypertrophic cardiomyopathy, and hyperparathyroidism \u2013 an association","volume":"54","author":"Symons","year":"1985","journal-title":"Brit Heart J"},{"key":"10.1016\/j.mehy.2003.12.054_bib38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1042\/cs0780127","article-title":"Blood pressure, left ventricular mass and intracellular calcium in primary hyperparathyroidism","volume":"78","author":"Dominiczak","year":"1990","journal-title":"Clin Sci (Lond.)"},{"key":"10.1016\/j.mehy.2003.12.054_bib39","first-page":"67","article-title":"Effects of parathyroidectomy on left ventricular mass in patients with hyperparathyroidism","volume":"21","author":"Sato","year":"1995","journal-title":"Miner Electrolyte Metab"},{"key":"10.1016\/j.mehy.2003.12.054_bib40","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0039-6060(97)90285-3","article-title":"Time course of regression of left ventricular hypertrophy after successful parathyroidectomy","volume":"121","author":"Stefenelli","year":"1997","journal-title":"Surgery"},{"key":"10.1016\/j.mehy.2003.12.054_bib41","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1365-2265.1999.00651.x","article-title":"Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy","volume":"50","author":"Piovesan","year":"1999","journal-title":"Clin Endocrinol (Oxf.)"},{"key":"10.1016\/j.mehy.2003.12.054_bib42","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/0002-9149(91)90410-M","article-title":"Influence of the arterial blood pressure and nonhemodynamic factors on left ventricular hypertrophy in moderate essential hypertension","volume":"68","author":"Bauwens","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.mehy.2003.12.054_bib43","first-page":"885","article-title":"Relationship between some humoral factors and left ventricular hypertrophy in essential hypertension","volume":"109","author":"Hui","year":"1996","journal-title":"Chin Med J (Engl.)"},{"key":"10.1016\/j.mehy.2003.12.054_bib44","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI0215219","article-title":"1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system","volume":"110","author":"Li","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mehy.2003.12.054_bib45","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1172\/JCI0216160","article-title":"Regulation of renin expression and blood pressure by vitamin D(3)","volume":"110","author":"Sigmund","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mehy.2003.12.054_bib46","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0895-7061(99)00126-0","article-title":"Modification of intracellular calcium and plasma renin by dietary calcium in men","volume":"12","author":"Petrov","year":"1999","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.mehy.2003.12.054_bib47","doi-asserted-by":"crossref","unstructured":"McCarty MF. Concurrent treatment with an ACE inhibitor may amplify the utility of calcium supplementation for control of hypertension. Med Hypotheses 2004 [in press]","DOI":"10.1016\/j.mehy.2002.11.001"},{"key":"10.1016\/j.mehy.2003.12.054_bib48","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/ajcn\/69.5.842","article-title":"Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety","volume":"69","author":"Vieth","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.mehy.2003.12.054_bib49","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/ajcn\/73.2.288","article-title":"Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level","volume":"73","author":"Vieth","year":"2001","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.mehy.2003.12.054_bib50","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1172\/JCI114043","article-title":"Physiologic regulation of the serum concentration of 1,25-dihydroxyvitamin D by phosphorus in normal men","volume":"83","author":"Portale","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mehy.2003.12.054_bib51","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1210\/en.143.2.587","article-title":"Dietary phosphorus transcriptionally regulates 25-hydroxyvitamin d-1\u03b1-hydroxylase gene expression in the proximal renal tubule","volume":"143","author":"Zhang","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.mehy.2003.12.054_bib52","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00041552-199607000-00006","article-title":"Effect of phosphate on the parathyroid gland: direct and indirect?","volume":"5","author":"Rodriguez","year":"1996","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.mehy.2003.12.054_bib53","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1159\/000189341","article-title":"A low-nitrogen low-phosphorus Vegan diet for patients with chronic renal failure","volume":"74","author":"Barsotti","year":"1996","journal-title":"Nephron"},{"key":"10.1016\/j.mehy.2003.12.054_bib54","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000045021","article-title":"Comparison of a vegetable-based (soya) and an animal-based low-protein diet in predialysis chronic renal failure patients","volume":"79","author":"Soroka","year":"1998","journal-title":"Nephron"},{"key":"10.1016\/j.mehy.2003.12.054_bib55","first-page":"F784","article-title":"Parathyroid hormone action on phosphate transporter mRNA and protein in rat renal proximal tubules","volume":"268","author":"Kempson","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1016\/j.mehy.2003.12.054_bib56","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/jcb.10338","article-title":"Vitamin D: a millenium perspective","volume":"88","author":"Holick","year":"2003","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.mehy.2003.12.054_bib57","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1079\/BJN2003837","article-title":"Vitamin D in preventive medicine: are we ignoring the evidence?","volume":"89","author":"Zittermann","year":"2003","journal-title":"Brit J Nutr"},{"key":"10.1016\/j.mehy.2003.12.054_bib58","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","article-title":"Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study","volume":"322","author":"Levy","year":"1990","journal-title":"New Engl J Med"},{"key":"10.1016\/j.mehy.2003.12.054_bib59","doi-asserted-by":"crossref","first-page":"345","DOI":"10.7326\/0003-4819-114-5-345","article-title":"Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension","volume":"114","author":"Koren","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.mehy.2003.12.054_bib60","doi-asserted-by":"crossref","first-page":"831","DOI":"10.7326\/0003-4819-117-10-831","article-title":"The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease","volume":"117","author":"Ghali","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.mehy.2003.12.054_bib61","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/978-1-4615-5385-4_21","article-title":"Comparison of therapeutic studies on regression of left ventricular hypertrophy","volume":"432","author":"Schmieder","year":"1997","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.mehy.2003.12.054_bib62","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3317\/jraas.2002.032","article-title":"Regression of left ventricular hypertrophy: hoping for a longer life","volume":"3","author":"Sharp","year":"2002","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.mehy.2003.12.054_bib63","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/BF00877918","article-title":"Salt intake, blood pressure, and cardiovascular structure","volume":"8","author":"Beil","year":"1994","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.mehy.2003.12.054_bib64","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1161\/01.CIR.94.6.1304","article-title":"Angiotensin II related to sodium excretion modulates left ventricular structure in human essential hypertension","volume":"94","author":"Schmieder","year":"1996","journal-title":"Circulation"},{"issue":"Suppl 2","key":"10.1016\/j.mehy.2003.12.054_bib65","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1097\/00005344-199117002-00028","article-title":"Left ventricular hypertrophy is more marked in salt-sensitive than in salt-resistant hypertensive patients","volume":"17","author":"Heimann","year":"1991","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.mehy.2003.12.054_bib66","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1161\/01.CIR.89.3.1023","article-title":"Effects on left ventricular hypertrophy of long-term nonpharmacological treatment with sodium restriction in mild-to-moderate essential hypertension","volume":"89","author":"Jula","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2003.12.054_bib67","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/nm1095-1009","article-title":"The effect of increased salt intake on blood pressure of chimpanzees","volume":"1","author":"Denton","year":"1995","journal-title":"Nat Med"},{"key":"10.1016\/j.mehy.2003.12.054_bib68","series-title":"Salt, diet and health: Neptune\u2019s poisoned chalice: the origins of high blood pressure","author":"MacGregor","year":"1998"},{"key":"10.1016\/j.mehy.2003.12.054_bib69","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00001573-200207000-00007","article-title":"Sodium and blood pressure","volume":"17","author":"de Wardener","year":"2002","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.mehy.2003.12.054_bib70","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00726-002-0212-0","article-title":"Treatment of hypertension with oral taurine: experimental and clinical studies","volume":"23","author":"Militante","year":"2002","journal-title":"Amino Acids"},{"key":"10.1016\/j.mehy.2003.12.054_bib71","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1161\/01.CIR.75.3.525","article-title":"Effects of increased adrenomedullary activity and taurine in young patients with borderline hypertension","volume":"75","author":"Fujita","year":"1987","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2003.12.054_bib72","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1253\/jcj.55.500","article-title":"Hypotensive action of taurine in DOCA-salt rats \u2013 involvement of sympathoadrenal inhibition and endogenous opiate","volume":"55","author":"Sato","year":"1991","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.mehy.2003.12.054_bib73","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/clc.4960080507","article-title":"Therapeutic effect of taurine in congestive heart failure: a double-blind crossover trial","volume":"8","author":"Azuma","year":"1985","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.mehy.2003.12.054_bib74","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/978-1-4899-1471-2_46","article-title":"Long-term effect of taurine in congestive heart failure: preliminary report. Heart Failure Research with Taurine Group","volume":"359","author":"Azuma","year":"1994","journal-title":"Adv Exp Med Biol"},{"issue":"Suppl 1","key":"10.1016\/j.mehy.2003.12.054_bib75","doi-asserted-by":"crossref","first-page":"s257","DOI":"10.1016\/0098-2997(94)90036-1","article-title":"Coenzyme Q10 in essential hypertension","volume":"15","author":"Digiesi","year":"1994","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.mehy.2003.12.054_bib76","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1097\/00007611-200111000-00015","article-title":"Randomized, double-blind, placebo-controlled trial of coenzyme Q10 in isolated systolic hypertension","volume":"94","author":"Burke","year":"2001","journal-title":"South Med J"},{"issue":"Suppl 1","key":"10.1016\/j.mehy.2003.12.054_bib77","doi-asserted-by":"crossref","first-page":"s287","DOI":"10.1016\/0098-2997(94)90040-X","article-title":"Italian multicenter study on the safety and efficacy of coenzyme Q10 as adjunctive therapy in heart failure. CoQ10 Drug Surveillance Investigators","volume":"15","author":"Baggio","year":"1994","journal-title":"Mol Aspects Med"},{"issue":"Suppl 1","key":"10.1016\/j.mehy.2003.12.054_bib78","doi-asserted-by":"crossref","first-page":"S159","DOI":"10.1016\/S0098-2997(97)00042-3","article-title":"Treatment of congestive heart failure with coenzyme Q10 illuminated by meta-analyses of clinical trials","volume":"18","author":"Soja","year":"1997","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.mehy.2003.12.054_bib79","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1161\/01.CIR.88.4.1431","article-title":"Insulin resistance is an important determinant of left ventricular mass in the obese","volume":"88","author":"Sasson","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2003.12.054_bib80","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/00004872-199504000-00009","article-title":"Left ventricular hypertrophy in hypertension is associated with the insulin resistance metabolic syndrome","volume":"13","author":"Lind","year":"1995","journal-title":"J Hypertens"},{"key":"10.1016\/j.mehy.2003.12.054_bib81","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0895-7061(96)00263-4","article-title":"Insulin resistance and cardiovascular complications in patients with essential hypertension","volume":"9","author":"Kamide","year":"1996","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.mehy.2003.12.054_bib82","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1097\/00004872-199917080-00015","article-title":"Effect of insulin resistance on left ventricular hypertrophy and dysfunction in essential hypertension","volume":"17","author":"Watanabe","year":"1999","journal-title":"J Hypertens"},{"key":"10.1016\/j.mehy.2003.12.054_bib83","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/0895-7061(96)87747-8","article-title":"Enhanced sympathetic nervous system activity. The linchpin between insulin resistance, hyperinsulinemia, and heart rate","volume":"9","author":"Facchini","year":"1996","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.mehy.2003.12.054_bib84","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/00004872-199917080-00016","article-title":"Relationship between insulin resistance and cardiac sympathetic nervous function in essential hypertension","volume":"17","author":"Watanabe","year":"1999","journal-title":"J Hypertens"},{"key":"10.1016\/j.mehy.2003.12.054_bib85","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/0002-9149(92)90981-4","article-title":"Role of diet and exercise in the management of hyperinsulinemia and associated atherosclerotic risk factors","volume":"69","author":"Barnard","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.mehy.2003.12.054_bib86","doi-asserted-by":"crossref","first-page":"M245","DOI":"10.1093\/gerona\/55.4.M245","article-title":"Effect of endurance exercise training on left ventricular size and remodeling in older adults with hypertension","volume":"55","author":"Turner","year":"2000","journal-title":"J Gerontol A: Biol Sci Med Sci"},{"key":"10.1016\/j.mehy.2003.12.054_bib87","first-page":"360","article-title":"Chronic continuous PTH infusion results in hypertension in normal subjects","volume":"2","author":"Hulter","year":"1986","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.mehy.2003.12.054_bib88","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/ndt\/12.5.933","article-title":"Subacute infusion of physiological doses of parathyroid hormone raises blood pressure in humans","volume":"12","author":"Fliser","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.mehy.2003.12.054_bib89","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/ajh\/1.4.397","article-title":"Hypertension in primary hyperparathyroidism \u2013 reduction of blood pressure by long-term treatment with vitamin D (\u03b1calcidol). A double-blind, placebo-controlled study","volume":"1","author":"Lind","year":"1988","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.mehy.2003.12.054_bib90","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/ki.1993.100","article-title":"Hyperparathyroidism, platelet intracellular free calcium and hypertension in chronic renal failure","volume":"43","author":"Raine","year":"1993","journal-title":"Kidney Int"},{"key":"10.1016\/j.mehy.2003.12.054_bib91","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1161\/01.HYP.30.2.150","article-title":"Ultraviolet light may contribute to geographic and racial blood pressure differences","volume":"30","author":"Rostand","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.mehy.2003.12.054_bib92","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1056\/NEJM199903253401214","article-title":"Seasonal changes in blood pressure in patients undergoing hemodialysis","volume":"340","author":"Rostand","year":"1999","journal-title":"New Engl J Med"},{"key":"10.1016\/j.mehy.2003.12.054_bib93","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(05)60827-6","article-title":"Ultraviolet B and blood pressure","volume":"352","author":"Krause","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2003.12.054_bib94","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/oxfordjournals.aje.a112050","article-title":"Blood pressure in vegetarians","volume":"100","author":"Sacks","year":"1974","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.mehy.2003.12.054_bib95","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/ajcn\/48.3.806","article-title":"Vegetarian diet and blood pressure levels: incidental or causal association?","volume":"48","author":"Beilin","year":"1988","journal-title":"Am J Clin Nutr"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987704002920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987704002920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T19:35:05Z","timestamp":1624390505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987704002920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":95,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0306987704002920"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2003.12.054","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}